ESCIRA● Request a pilot

AI‑NATIVE DECISION INTELLIGENCE

For advisors, investors and enterprises

Stronger companies.
Smarter decisions.

ESCIRA turns founder input and AI-powered research into one clear, standardized assessment. Advisors use it to get companies investment-ready. Investors use it to make better investment decisions. Enterprises use it to find companies worth backing.

Built for institutions, not founders Every claim sourced A person signs every report
HOW IT FITS TOGETHER 01 Get ready FOR ADVISORS What the company has to prove, in what order, and what it costs. 02 Decide FOR INVESTORS What is verified, what is only claimed, and whether to invest. 03 Connect FOR ENTERPRISES Companies already assessed, introduced when they fit. Every step is written down and dated. That record is the third product.

One standard

Every company looked at the same way, in the same order.

Nothing taken on trust

Each claim is marked as checked by us, or simply stated by the company.

A person signs it

An analyst reviews the work. A named ESCIRA principal signs it.

THE PROBLEM

The decision comes first.
The evidence comes later.

A pre-seed company—one that has not yet raised its first big round—has no audited numbers and almost no history. So the judgment falls to people who are short of hours: advisors with full client lists, investors with full pipelines. Most of it still gets done by reading a slide deck.

EVIDENCE THE EVIDENCE ARRIVES HERE THE DECISION IS MADE HERE Almost nothing is proven yet. Most of what is on the table is a slide deck. the pitch deck IdeaPre-seedSeedSeries A first customersaudited numbers
Illustration only. The shape of the problem, not measured data.

WHAT WE DO

Three things, in order.

01 · FOR ADVISORS

Get the company ready, and funded.

What it has to prove to become pre-seed investment ready, in what order, what proving it will cost—and which funders to approach once it is.

02 · FOR INVESTORS

Decide whether to invest.

What is verified, what is only claimed, and a clear recommendation with the reasons behind it.

03 · FOR ENTERPRISES

Meet the ones that fit.

Companies already assessed, introduced for investment, partnership, licensing, or acquisition.

FOR ADVISORS

Get your clients
ready, faster.

You already know what these companies need. ESCIRA does the reading, the research and the write-up, so your hours go to the conversation instead of the homework—better and less expensively than you can do it today.

  • A ranked list of what each company must prove
  • A ninety-day plan, with two checkpoints along the way
  • The same standard for every client, so you can compare them
  • Delivered under your own brand, if you prefer

Accelerators · incubators · venture studios · advisory firms · economic development programs

A ninety-day plan for an example company, showing five pieces of work laid out across ninety days with two checkpoints and a target close.
The ninety-day plan. Sample page from an example company that does not exist.

FOR INVESTORS

Decide with the
claims tested.

Almost everything you are handed was written by someone raising money. ESCIRA reads it against itself and against the outside world, then tells you which parts hold up.

  • Every claim marked: checked by us, or stated by them
  • A plain recommendation, and the reasoning behind it
  • The questions to ask before you write a check
  • No single overall score—each finding points to its own action

Angel groups · pre-seed funds · family offices · and the advisors above, who often invest too

A page testing four claims an example company makes about why it wins, each given a verdict of real, contested, real but absorbable, or not supported.
Each claim, read the way a skeptic would read it. Sample page from an example company that does not exist.

FOR ENTERPRISES

See the companies
worth your time.

An enterprise is not only asking whether a company is a good investment. It is asking whether the company fits, whether it could survive a pilot inside a large organization, and whether buying or licensing beats building.

  • Companies already assessed to one standard
  • Introduced for investment, partnership, licensing or acquisition
  • A read on whether the market timing is in your favor
  • Nothing shared without the company agreeing to it first

Enterprise venture arms · innovation and scouting teams · strategic acquirers

A page listing the forces acting on a sector and what each one does to timing, for an example company.
Is the window open? Sample page from an example company that does not exist.

HOW IT WORKS

Machine speed.
Human judgment.

A founder sends what they have. AI reads all of it and goes looking for what is missing. A person checks the result before it leaves the building.

01 02 03 04 WHAT WE START WITH WHAT WE ADD BEFORE IT GOES OUT WHAT YOU GET One short form from the founder The company's own documents Anything else they want to share THE AI DOES THE READING Reads every page they send Looks for what is missing Searches outside sources Checks claims against the record Says what it could not confirm THE SAME QUESTIONS EVERY TIME Four areas, scored the same way How much we verified: A to E How far along they are: 1 to 6 The two are never blended Risks listed one by one An automatic check runs first Nothing missing, nothing unsourced A person reads the whole thing Each claim marked verified or stated A named principal signs it A plan for the advisor A brief for the investor Funders worth approaching Your brand on it, if you want AND WHAT BUILDS UP Every report is dated and kept. Do that enough times and you have a record of early-stage companies that nobody else has.

SECTORS

What counts as proof
is not the same
in every field.

A drug company and a marketplace do not prove themselves the same way. We keep a separate set of questions for each field we cover, so a company is measured against what actually matters in its own.

  • Applied and vertical AI software
  • Health and digital health
  • Data, cloud and AI infrastructure
  • Climate and industrial technology
  • Marketplaces and platforms
  • Life sciences and therapeuticsIN DEVELOPMENT
  • Medical device hardwareIN DEVELOPMENT

THE THIRD PRODUCT

A record that did
not exist before.

Every assessment is dated and kept: what was known then, what was still uncertain, and what happened afterward. Do that enough times and you have a picture of how early companies really develop—because nobody was writing it down this early.

Our rule on this.

Nothing that identifies a company leaves ESCIRA unless that company and the institution working with it agree to it in writing. Anything we build for a wider audience is made from combined results in which no company is named—never a company’s own file passed along.

Research products and introductions are offered as they become available.

  • What was claimed, and when
    The original call, with its date, kept exactly as written.
  • What could be verified
    And what could not—which is often the more useful half.
  • What happened next
    A short check-in each week, so the record shows movement, not just a starting point.
  • Across many companies
    Patterns that no single program or fund can see on its own.

WHERE THE LINE SITS

We look and we measure.
You decide and you act.

WHAT WE DO

  • Look at the company against one standard
  • Separate what is proved from what is claimed
  • Name the gaps and what would close them
  • Check again later and report what moved

WHAT WE DO NOT DO

  • Advise the founder directly—that is your job
  • Give patent or other legal opinions
  • Tell you to invest, or not to
  • Boil a company down to a single number

We keep the looking separate from the acting on purpose. It keeps our read honest, and it leaves legal questions with the lawyers who carry the risk for answering them. ESCIRA provides educational decision support—not investment, legal or regulatory advice.

PRICING

Subscribe.
Assess as needed.

Institutions buy ESCIRA. Founders get the benefit of the work. Reports are billed per company, so the cost follows your workload.

Nobody logs in to anything. You send us a company. We do the research, write it up, and a named principal signs it—back to you within two business days of a complete intake.

$249/ month

What recurs every month: the standard applied the same way to every company, the record kept and dated, and the weekly check-in run for you.

$600/ bundle

One company, written up two ways: a plan for the advisor and a brief for the investor.

$750/ report

A deeper look into your client’s technology and where it sits against everything else out there.

For example: three months, with ten advisor and investor bundles, comes to $6,747. Scope and delivery are confirmed with ESCIRA before anything starts. A group of companies arriving at once is scheduled with you in advance.

WHO WE ARE

Operators who have
run companies before.

Paul Wedeking

FOUNDER AND PRESIDENT

CEO at NTELX, Lusynt and Wedeking LLC. Managing Director at IBM, Principal at A.T. Kearney, Partner at AT&T Solutions, Partner at Blue Ridge Partners, Senior Vice President at DATUM.

Jason Pelletier

CHIEF EXECUTIVE OFFICER

CEO at Quantum Power Systems. Senior Director of Partnerships at Future Analytics. Director of Strategic Partnerships at KiwiTech.

Dr. Matthew C. Heim

CHIEF STRATEGY OFFICER, EZASSI

Thirty years running the companies that sell innovation programs to large corporations—NineSigma, inno360, AMPLYFI, Clarkston Consulting and PwC.

Dr. Dan Cohrs

CHIEF FINANCIAL OFFICER, EMERJA

A career finance chief who has raised money at every scale, at D-Wave, Global Crossing and Rentech Nitrogen. Formerly taught finance at Harvard Business School.

Robert Rudelius

CHIEF EXECUTIVE OFFICER, MEDICAMETRIX

Former Founder and CEO of NobleVentures. Former Partner at McKinsey & Company. Former Managing Partner at AT&T Solutions.

Corporate counsel: Sheppard, Mullin, Richter & Hampton.

QUESTIONS

Frequently asked
questions.

Straight answers to what institutions ask us first.

What does ESCIRA actually deliver?

A finished, signed report on one company. It shows what the company has proved, what it has only claimed, and what it should do next.

Advisors get a ranked list of what to prove and a ninety-day plan. Investors get a brief with a plain read and the questions to ask before writing a check.

Who buys ESCIRA?

Institutions: accelerators, incubators, advisory firms, economic development programs, angel groups, pre-seed funds, family offices and enterprise venture teams.

We do not sell to founders. Founders reach us through the program or investor working with them.

Do we need to log in or install anything?

No. You send us a company. We do the research, write it up, and send back a finished report.

How long does a report take?

Two business days from a complete intake. If a group of companies arrives at once, we agree the schedule with you in advance.

What does a founder have to provide?

One short form, the company’s own documents, and anything else they want to share. Nothing has to be prepared specially for us.

How do you tell what is proved from what is only claimed?

Every claim in the report is marked as either checked by us or stated by the company. We also grade how much we could verify, from A to E, and how far along the company is, from 1 to 6.

The two grades are never blended into one score, so a strong story cannot hide thin evidence.

What happens when information is missing?

The report says it was not provided and explains why that matters. We never estimate or fill in a missing number. Often, what is missing is the most useful part of the report.

Do you use AI? Who checks the work?

Yes. AI reads every page, searches outside sources and checks claims against the record. An automatic check then confirms nothing is missing or unsourced.

A person reads the whole report, and a named ESCIRA principal signs it before it goes out.

How do you protect company information?

Each client’s work is kept separate. Our AI providers work under business terms that do not use your information to train their models.

We delete company files twelve months after your subscription ends, or sooner if you ask. Nothing that identifies a company leaves ESCIRA without that company’s and your written agreement.

Is this investment or legal advice?

No. ESCIRA provides educational decision support. We show what is proved, what is claimed and why it matters. The decision, and any action, stays with you.

We do not give patent or other legal opinions. Those stay with the lawyers who carry the risk for answering them.

CONTACT

Start the
conversation.

Tell us about your clients, your pipeline, or the companies you are scouting. We will come back with a proposed scope and what a first assessment would cover.

info@escira.ai

We reply to every inquiry from an institution.

GENERALinfo@escira.ai
LOCATIONAlexandria, Virginia
WHO WE SELL TOInstitutions only. Founders reach us through the program or investor working with them.
 Request a pilot

About the sample pages on this site. Every report page shown here comes from an example company built to test our standards. Those companies do not exist. No client data, and no real company’s assessment, appears anywhere on this page. Figures inside the samples are drawn from the materials of companies that are not real, and are not forecasts, benchmarks, or claims about any actual business.